BioNTech (BNTX) director Anja Morawietz reports initial 240-share stake

Rhea-AI Filing Summary

BioNTech SE director Anja Morawietz has filed an initial ownership report showing a modest equity stake in the company. The filing lists beneficial ownership of 200 ordinary shares held directly and an additional 40 ordinary shares held indirectly by her immediate family, as described in the footnote. This Form 3 does not report any recent share purchases or sales; it simply establishes her current holdings as she becomes a reporting insider.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Morawietz Anja

Role Director

Type	Security	Shares	Price	Value
holding	Ordinary Shares	--	--	--
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Ordinary Shares — 200 shares (Direct); Ordinary Shares — 40 shares (Indirect, See Footnote)

Footnotes (1)

1. [object Object]

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Morawietz Anja

(Last) (First) (Middle)

C/O BIONTECH SE

AN DER GOLDGRUBE 12

(Street)

MAINZ D-55131

(City) (State) (Zip)

GERMANY

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
BioNTech SE [ BNTX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	200	D
Ordinary Shares	40	I	See Footnote(1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The ordinary shares are held by the Reporting Person's immediate family.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney

	/s/ Humza Bokhari, Attorney-in-Fact	03/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the BioNTech (BNTX) Form 3 filed by Anja Morawietz show?

The Form 3 shows that director Anja Morawietz beneficially owns 200 ordinary shares of BioNTech directly and 40 ordinary shares indirectly through her immediate family. It is an initial ownership report, not a record of recent trades.

How many BioNTech (BNTX) shares does Anja Morawietz hold directly and indirectly?

The filing reports 200 ordinary shares of BioNTech held directly by Anja Morawietz and 40 ordinary shares held indirectly. The indirect shares are described in the footnote as being held by her immediate family, reflecting additional beneficial ownership.

Does the BioNTech (BNTX) Form 3 for Anja Morawietz show any recent buying or selling?

No, the Form 3 does not show recent buying or selling. It records holding entries only, listing 200 ordinary shares directly owned and 40 ordinary shares indirectly owned through immediate family, establishing her stake as a new reporting insider.

What is the significance of indirect ownership in the BioNTech (BNTX) Form 3?

Indirect ownership indicates shares held through related persons or entities. In this BioNTech filing, 40 ordinary shares are held by Anja Morawietz’s immediate family. These are reported as indirectly owned but still count toward her overall beneficial ownership stake.

Is the Anja Morawietz BioNTech (BNTX) Form 3 considered a major transaction filing?

No, this Form 3 is not a major transaction filing. It simply discloses initial beneficial ownership of 200 directly held and 40 indirectly held BioNTech ordinary shares as she assumes reporting obligations as a company director.